While colon cancer has traditionally been associated with older adults, recent data reveals an alarming trend: cases are ...

New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...

A young mother has revealed the symptoms that led to her stage 3 colorectal diagnosis. About 150,000 Americans are diagnosed ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

Doctors in Dallas and other parts of Texas are beginning to use a new blood test that can detect colon cancer earlier. The ...

Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...

A study revealed that probiotics combined with chemotherapy and immune checkpoint inhibitors improve survival, gut health, ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

Pfizer (PFE) announced positive topline results from the progression-free survival – PFS – analysis of the Phase 3 BREAKWATER study of Braftovi ...

Experts agree that early detection and treatment are key to survival with colorectal and other cancers.